The Brain Tumor Trials Collaborative develops and performs state-of-the-art clinical trials, advancing treatments for patients with brain tumors through collaborative research.
Merging good scientific method with concern for patient well-being and outcome
Developing innovative clinical trials using the latest scientific methods and technologies in neuro-oncology.
A network of leading medical centers working together in a collegial environment to advance brain tumor treatments.
Merging scientific excellence with compassion and understanding for patient well-being and outcomes.
The Brain Tumor Trials Collaborative (BTTC) was created in 2003 as a network of medical centers with the expertise and desire to participate in state-of-the-art clinical trials investigating new treatments for malignant brain tumors.
This network of institutions allows patients across a broad geographic range to participate in cutting-edge clinical trials and more rapidly determine the benefits of various therapies for malignant gliomas—the most common brain tumor in adults.
2003
Year Founded
15+
Partner Institutions
Advancing treatment therapies for malignant gliomas and other brain tumors
Investigating innovative therapeutic strategies to improve tumor control and increase survival rates for patients with malignant brain tumors.
Enabling patients across diverse geographic locations to access cutting-edge clinical trials and contribute to faster determination of therapeutic benefits.
Publishing results in leading peer-reviewed journals including the Journal of Neuro-Oncology and Neuro-Oncology to advance the field.
Leading medical centers committed to discovering new and effective therapies
Leading universities and teaching hospitals with neuro-oncology expertise
Board-certified neuro-oncologists and specialists in brain tumor treatment
Network spanning multiple regions to serve patients nationwide
Learn more about BTTC clinical trials and participating institutions
If you or a loved one has been diagnosed with a brain tumor, speak with your oncologist about BTTC clinical trials that may be available in your area.
Medical institutions interested in joining the BTTC network or referring patients to clinical trials can contact us directly.